-
公开(公告)号:US11730699B2
公开(公告)日:2023-08-22
申请号:US17147007
申请日:2021-01-12
Applicant: Alcon Inc.
Inventor: Howard Allen Ketelson , James W. Davis , Rekha Rangarajan
IPC: A61K31/736 , A61P27/02 , A61K9/00 , A61K9/107 , A61K47/14 , A61K47/24 , B01F17/00 , A61K47/02 , A61K47/10 , A61K47/26 , A61K47/34 , A61K47/36 , B82Y5/00
CPC classification number: A61K9/1075 , A61K9/0048 , A61K47/02 , A61K47/24 , A61K47/26 , A61K47/34 , A61K47/36 , B82Y5/00
Abstract: The present invention is directed to a lipid-based ophthalmic emulsion. The emulsion has an increased amount of a mucoadhesive galactomannan polymer that promotes a long-lasting protection against desiccation and moisture retention.
-
公开(公告)号:US11672820B2
公开(公告)日:2023-06-13
申请号:US17664143
申请日:2022-05-19
Applicant: Alcon Inc.
Inventor: James W. Davis , Howard Allen Ketelson , Elaine E. Campbell , David L. Meadows , Rekha Rangarajan
IPC: A61K31/736 , A61K9/00 , A61K47/02 , A61K47/10 , A61K47/26 , A61K47/36 , A61K47/32 , A61K31/728
CPC classification number: A61K31/736 , A61K9/0048 , A61K31/728 , A61K47/02 , A61K47/10 , A61K47/26 , A61K47/32 , A61K47/36
Abstract: The present invention relates to artificial tear compositions and ophthalmic compositions suitable for drug delivery. In one embodiment of the present invention, the compositions comprise a galactomannan polymer such as guar or hydroxypropyl guar, hyaluronic acid, and a cis-diol such as sorbitol. In a preferred embodiment, the compositions also comprise a borate compound.
-
公开(公告)号:US20220273699A1
公开(公告)日:2022-09-01
申请号:US17664143
申请日:2022-05-19
Applicant: Alcon Inc.
Inventor: James W. Davis , Howard Allen Ketelson , Elaine E. Campbell , David L. Meadows , Rekha Rangarajan
IPC: A61K31/736 , A61K9/00 , A61K47/02 , A61K47/10 , A61K47/26 , A61K47/36 , A61K47/32 , A61K31/728
Abstract: The present invention relates to artificial tear compositions and ophthalmic compositions suitable for drug delivery. In one embodiment of the present invention, the compositions comprise a galactomannan polymer such as guar or hydroxypropyl guar, hyaluronic acid, and a cis-diol such as sorbitol. In a preferred embodiment, the compositions also comprise a borate compound.
-
公开(公告)号:US11306090B2
公开(公告)日:2022-04-19
申请号:US16760192
申请日:2018-11-02
Applicant: Alcon Inc.
Inventor: David Ellis , Howard Allen Ketelson
IPC: C07D471/08 , A61P27/10 , A61K9/00 , C07D243/38 , C07D471/04
Abstract: The present invention provides in one aspect azabicyclo and diazepine derivatives useful as modulators of muscarinic receptors. In another aspect, the present invention provides pharmaceutical compositions for treating ocular diseases, the compositions comprising at least one muscarinic receptor modulator.
-
公开(公告)号:US20210060056A1
公开(公告)日:2021-03-04
申请号:US17060343
申请日:2020-10-01
Applicant: Alcon Inc.
Inventor: James W. Davis , Howard Allen Ketelson , Elaine E. Campbell , David L. Meadows , Rekha Rangarajan
IPC: A61K31/736 , A61K9/00 , A61K47/02 , A61K47/10 , A61K47/26 , A61K47/36 , A61K47/32 , A61K31/728
Abstract: The present invention relates to artificial tear compositions and ophthalmic compositions suitable for drug delivery. In one embodiment of the present invention, the compositions comprise a galactomannan polymer such as guar or hydroxypropyl guar, hyaluronic acid, and a cis-diol such as sorbitol. In a preferred embodiment, the to compositions also comprise a borate compound.
-
公开(公告)号:US20240166691A1
公开(公告)日:2024-05-23
申请号:US18503390
申请日:2023-11-07
Applicant: Alcon Inc.
Inventor: Howard Allen Ketelson , Rekha Rangarajan
IPC: C07K7/64
CPC classification number: C07K7/645
Abstract: The present disclosure is directed to prodrugs, compositions including prodrugs, and methods for administering prodrugs and compositions thereof to a patient, including prodrugs represented by Formula (I):
wherein: D is a drug moiety; Q is an oxygen atom, a sulfur atom, or a nitrogen atom; X is a chemical bond or
each of G, G′, and G″ is independently an oxygen atom or a sulfur atom; L is a polyether; T is a hydrogen atom, a hydroxyl group, a thiol group, a boronic acid group, or an amine group; R1 is selected from the group consisting of a substituted aryl group, unsubstituted aryl group, and a substituted carbonyl group; and each of R2, R3, R1′, R2′, R3′, and R4′ is independently a hydrogen atom, a substituted C1-C20 alkyl group, or an unsubstituted C1 -C20 alkyl group. In at least one embodiment, a composition comprises a compound and a carrier material.-
公开(公告)号:US11884666B2
公开(公告)日:2024-01-30
申请号:US17699606
申请日:2022-03-21
Applicant: Alcon Inc.
Inventor: David Ellis , Howard Allen Ketelson
IPC: C07D471/08 , A61P27/10 , A61K9/00 , C07D243/38 , C07D471/04
CPC classification number: C07D471/08 , A61K9/0048 , A61P27/10 , C07D243/38 , C07D471/04
Abstract: The present invention provides in one aspect azabicyclo and diazepine derivatives useful as modulators of muscarinic receptors. In another aspect, the present invention provides pharmaceutical compositions for treating ocular diseases, the compositions comprising at least one muscarinic receptor modulator.
-
公开(公告)号:US20230201112A1
公开(公告)日:2023-06-29
申请号:US18145256
申请日:2022-12-22
Applicant: Alcon Inc.
Inventor: Howard Allen Ketelson , Rekha Rangarajan , Patrick John Sadd
CPC classification number: A61K9/0051 , A61K9/70 , A61K47/36 , A61K47/32 , A61K47/10
Abstract: A dissolvable medical device for protecting a corneal surface and providing lubrication and hydration to the corneal surface during ophthalmic surgery comprising: a polymeric film has sufficient dimensions to substantially cover a cornea when applied to an eye, wherein the polymeric film comprising one or more mucoadhesive polymers. The polymeric film dissolves between 15 minutes to 120 minutes to release the mucoadhesive polymers after applying the polymeric film to the eye and the polymeric film provides more effective corneal surface protection relative to a saline treatment based on Mean Green Fluorescence Index test (demonstrates corneal damage) during a simulated surgery. In addition, a kit for use in ophthalmic surgical procedures comprises 1) the at least one dissolvable medical device and 2) at least one viscosurgical viscoelastic or at least one ophthalmoscopic surgical contact lens.
-
公开(公告)号:US11234929B2
公开(公告)日:2022-02-01
申请号:US16811461
申请日:2020-03-06
Applicant: Alcon Inc.
Inventor: Howard Allen Ketelson , David L. Meadows
Abstract: The present invention is directed to an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The emulsion also includes a mucoadhesive polymer that aid in delivering a lipid to the ocular surface.
-
公开(公告)号:US20210179616A1
公开(公告)日:2021-06-17
申请号:US16760192
申请日:2018-11-02
Applicant: Alcon Inc.
Inventor: David Ellis , Howard Allen Ketelson
IPC: C07D471/08 , C07D471/04 , C07D243/38 , A61K9/00 , A61P27/10
Abstract: The present invention provides in one aspect azabicyclo and diazepine derivatives useful as modulators of muscarinic receptors. In another aspect, the present invention provides pharmaceutical compositions for treating ocular diseases, the compositions comprising at least one muscarinic receptor modulator.
-
-
-
-
-
-
-
-
-